Professional Documents
Culture Documents
I2I
Ccile Cabanis Emmanuel Faber
2016 FINANCIAL RESULTS DANONE PROGRESS REPORT
I3I
Ccile Cabanis
2016 FINANCIAL RESULTS
2016: year of robust performance leading to very strong EPS growth
GROWTH PROFIT
AGILITY CONSISTENCY
+16.8%
+9.3%(1)
+6.5%(1) +9.2%
1,786
3.10 1,529
2.93 1,401
2.62
recurring
sales recurring
growth operating
margin EPS
I8I
2016 Like-for-like sales growth of +2.9%
Reported -2.1%
22,412 mln
Like-for-like +2.9%
21,944 mln
(5.5)%
3.1%
FY 2015 FY 2016
NORAM
EUROPE ALMA
CIS AsiapacLatamMiddleEastAfrica
USA+Canada+CIS
0.0%
5.7% 8.0% 6.8%
5.1% 4.8% 6.3%
(0.2)% 5.4%
(2.7% (2.9)% 2.8%
Q1 16 Q2 16 Q3 16 Q4 16 Q1 16 Q2 16 Q3 16 Q4 16 Q1 16 Q2 16 Q3 16 Q4 16
FY 2015 FY 2016
Q1 16 Q2 16 Q3 16 Q4 16
I 11 I
Waters: sustained strong profitable growth,
transition in China in progress
Price/mix 0.0%
11.37% 11.38%
Volume (2.5)% (2.8)% (0.1)% (0.4)%
FY 2015 FY 2016
Q1 16 Q2 16 Q3 16 Q4 16
I 12 I
Early Life Nutrition: solid fundamentals of profitable growth,
continued transition in China towards sustainable model of growth
+4.8%
+5.3%
+3.5% +1.7%
+0.6% 21.91%
19.32%
Price/mix +1.3% +1.9% +2.1%
+1.1%
Volume (0.4)% (0.5)%
FY 2015 FY 2016
Q1 16 Q2 16 Q3 16 Q4 16
> Solid growth outside China, volatility in China driven by e-commerce conversion
> Operating margin increase driven by growth and mix, positive reverse of 2015 one off costs
I 13 I
Medical Nutrition: sustaining very strong profitable growth
+7.1% +3.7%
+6.6% +6.1%
Price/mix +1.4% +2.9% +2.1%
19.71%
Volume 17.95%
+6.0%
+5.2% +4.2% +4.0%
FY 2015 FY 2016
Q1 16 Q2 16 Q3 16 Q4 16
I 14 I
2016 key highlights
recurring
sales recurring
growth operating
margin EPS
I 15 I
Very strong improvement in recurring operating margin
Efficiencies + 50 bps
(88) bps
+116 bps Portfolio management + 30 bps
+43 bps
+10 bps +6 bps
Reinvest Others Input Costs + 40 bps
Forex Margin
Scope from
operations
13.77%
12.91%
2015 2016
Reported Reported
I 16 I
2016 key highlights
recurring
sales recurring
growth operating
margin EPS
I 17 I
Very strong Like for Like recurring EPS growth illustrating major progress
in strengthening the model
Reported +5.6%
Like-for-like +9.3%
+0.5% +0.3%
Taxes
FR + (5.2)%
+5.5% Others
+1.5%
Forex Scope
+2.9% Margin
3.10
Net Sales
2.93
2015 2016
Recurring Recurring
EPS EPS
I 18 I
FCF: very strong cash delivery
Cash delivery
Free cash-flow excluding exceptional items ( mln)
+16.8%
+9.2%
1,786
1,529
1,401
(0.3)
+0.3
(1.8) Others
+1.1
+0.1
FCF M&A Dividends
Puts
7.8 7.5
I 20 I
Balance sheet
Assets (1) bn
Liabilities
Dec. 2015 Dec. 2016 Dec. 2015 Dec. 2016
12,669 13,194
15,803
Intangible assets 15,779 Shareholders equity
6,193 6,513
Working capital 4,632 4,964 Working capital
1.70
1.60
1.50
1.39 1.45 1.45
1.30
1.20 1.20
1.10
1.00
0.85
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
I 22 I
2017: decoupling growth and efficiency agenda
EPS
>5%(1)
Consistent EPS growth
(1) Like-for-like I 23 I
Emmanuel Faber
DANONE PROGRESS REPORT
The revolution towards changing the way people eat and drink
I 25 I
We continue to assemble and grow an unparalleled portfolio
of healthy diet categories
% CAGR 2011-2016 Global Retail Value Growth
8
Danone leader positions
(in value)
Organic
6
*
#1 #3
Organic
* Num 2 in volume
4
#2 #1
#1
2
Free Energy Organic Baby Enteral Bottled Organic Milk Aquadrinks(2) Fruits Vitamin Dairy(3) Ice cream Confectionary Baked Juice CSD Breakfast
from bar packaged food nutrition(1) water beverages alternatives snack & dietary & frozen goods cereals
Gluten foods deserts
Sources: Euromonitor. Retail Sales 2011 - 2016 ; Constant 2016 prices; (1) Source: Kalorama Information 2012 Note: Allergy category not included in this
data (2) Source for aquadrinks: Canadean 27 countries, Date: 2008 2014, (3) Aggregation of butter and margarine, drinking milk products, cheese,
yoghurt and sour milk drinks, and other dairy products. I 26 I
Successes and still some challenges
Challenges Successes
I 27 I
2016: a year of significant progress
+4.7% +4.4%
+9.3% +16.8%
(1) (2)
FY 2014 FY 2015
2016
+
Changing the way the world
eats for the better
I 29 I
WhiteWave
A perfect combination to strengthen Danone 2020 plan
TAKING THE SUSTAINABILITY EQUATION DOUBLING THE SIZE
OF DAIRY AND PLANT-BASED OF DANONE IN THE US
TO THE NEXT LEVEL ABOVE $6 BN
+
Fastest growing food & beverage
company in the US(1)
Opportunities within Danone 2020 plan
to reduce agricultural impact Entering the US top 15
food & beverage league(2)
Improve nutritional density of global portfolio
Ebit margin
Significant synergies Accretive year 2
EPS
Accretive to Danone Solid accretion from Year 1
equation >10% accretion (1)
I 32 I
Step up our ability to seize consumer opportunities
and work more efficiently
2 NEW ROLES
I 33 I
Decoupling Danones mid term growth transformation agenda
and our immediate efficiency agenda
2020
EFFICIENCY
GROWTH
2017
Consistent
EPS growth
I 34 I
Alimentation Revolution calling for brands engaging in a new way
with their communities of consumers
I 35 I
Alimentation Revolution calling for a new marketing model
I 36 I
Alimentation Revolution calling for a marketing
and innovation transformation
New Growth and Innovation board
I 37 I
Danone: a unique position and culture
to lead the Alimentation Revolution
I 38 I
Launching a comprehensive, company-wide program
to maximize efficiency
Disciplined
Choices Maximize Efficiency PROGRAM
Sustainably
PROTEIN
BUY BETTER SCOPE
I 39 I
Delivering efficiency and resources
for the short, mid and long term
Program PROTEIN
Global procurement organization
New CPO Role
Strategic
Resources
Cycles &
Operations
I 40 I
Decoupling Danones growth & efficiency agendas
2020
EFFICIENCY
GROWTH
2017
Consistent Fuel the growth
EPS growth model
I 41 I
Keep building a stronger model of growth
I 42 I
APPENDIX
Q4 & FY 2016 impact of currencies & scope
Q4 2016 Fresh Dairy Products Waters Early Life Nutrition Medical Nutrition Total
Reported sales growth (0.2)% (1.0)% (1.1)% +0.9% (0.5)%
Currency (2.5)% (7.0)% (1.1)% (3.4)% (3.1)%
Scope of consolidation +1.6% (0.3)% (0.6)% (1.8)% +0.5%
Like-for-like sales growth +0.7% +6.3% +0.6% +6.1% +2.1%
FY 2016 Fresh Dairy Products Waters Early Life Nutrition Medical Nutrition Total
Reported sales growth (2.9)% (4.1)% +0.5% +1.5% (2.1)%
Currency (6.3)% (6.9)% (3.0)% (4.0)% (5.5)%
Scope of consolidation +1.4% (0.1)% (0.0)% (1.9)% +0.5%
Like-for-like sales growth +2.0% +2.9% +3.5% +7.4% +2.9%
I 45 I
Changes in exchange rates
I 46 I
Recurring operating margin by geographical area
I 47 I
From operating income to EPS
I 48 I
Cash bridge
744 (852)
Depreciation (280) 44
Taxes
Financial (1) W cap var
results (925)
Others 33
3,022 Capex Sales of (26)
2,632
assets and Plan for
Transaction 1,786 savings and 1,760
Fees adaptation
in Europe
Recurring Cash from FCF excl FCF
Operating operating European reported
income activities plan
I 49 I
Tax rate development
2015 2016
Operating income 2,892 3,022
Financial income (282) (280)
Income tax (818) (852)
Non-current income (493) (64)
Depreciation and amortization 1,217 786
Net change in provisions / Deferred taxes (31) (15)
Dividend reveived from equity accounted affiliates 40 53
Net change in interest income (expense) (30) 0
Expense related to stock options and GPS 27 24
Other items 30 (60)
Cash flow provided by operating activities,
excluding changes in net working capital
2,552 2,615
I 51 I
Cash-flow statement
2015 2016
Cash flow provided by operating activities,
excluding changes in net working capital
2,552 2,615
Change in working capital (182) 37
Cash flow from operations 2,369 2,652
Capital expenditure (937) (925)
Proceeds from the sale of industrial assets 31 27
Business acquisitions and other investments, (596) (66)
net of cash and cash equivalent acquired
Proceeds from the sale of business 2 110
Change in long-term loans and other long-term assets (19) 6
Cash flow used in investing activities and disposals 1,519 (848)
I 52 I
Cash-flow statement
2015 2016
Cash flow used in investing activities and disposals 1,519 (848)
Increase in capital and additional paid-in capital 39 46
Purchases of treasury stock (net of disposal) 198 32
Dividends paid to Danone shareholders (314) (985)
Transactions with non controlling interests* (2,029) (383)
Settlement of debt hedge financial instruments 22 50
Bonds issued or raised during the period 2,049 11,237
Bonds repaid during the period (603) (638)
Increase (decrease) in other current and non-current financial debt (101) (442)
Increase (decrease) in other short-term investments (242) (10,531)
Cash flow used in financing activities (982) (1,616)
Exchange rate differances and others (228) (151)
Increase (decrease) in cash (361) 38
* Including dividends and capital increase
I 53 I
Stock price & shareholding
Danone 2016 stock price evolution(1) Danone 2016 stock performance(1)
(1) At 31/12/2016
(2) Based on the survey conducted by Danone of its identifiable shareholders in December 2016 I 54 I
2016 ADR program
DRs Outstanding as a % of Total Shares Outstanding
220 Data as of December 31, 2016 6%
DRs Outstanding (Mln)
200
180 5%
160
4%
140
120
3%
100
80
2%
60
40 1%
20
0 0%
01/01/2016 02/15/2016 03/29/2016 05/11/2016 06/23/2016 08/05/2016 09/19/2016 11/01/2016 12/14/2016
Like-for-like changes in Sales, Recurring operating income, Recurring operating margin, Recurring net income and recurring EPS reflect Danone's organic
performance and essentially exclude the impact of:
changes in consolidation scope with indicators related to a given fiscal year calculated on the basis of previous-year scope;
changes in applicable accounting principles;
changes in exchange rates, (i) with both previous-year and current-year indicators calculated using the same exchange rates (the exchange rate used is a
projected annual rate determined by the Company for the current year and applied to both previous and current year), and (ii) correcting differences
caused by the exceptional volatility of inflation in countries that are structurally subject to hyperinflation, which would otherwise distort any interpretation of
Danone's organic performance.
Recurring operating income is defined as Danones operating income excluding Other operating income and expenses. Other operating income and expenses
is defined under Recommendation 2013-03 of the French CNC (format of consolidated financial statements for companies reporting under international reporting
standards), and comprises significant items that, because of their exceptional nature, cannot be viewed as inherent to its recurring activities. These mainly
include capital gains and losses on disposals of fully consolidated companies, impairment charges on goodwill, significant costs related to strategic restructuring
and major external growth transactions, and costs related to major crisis and major litigations. Furthermore, in connection with of IFRS 3 (Revised) and IAS 27
(Revised) relating to business combinations, the Company also classifies in Other operating income and expenses (i) acquisition costs related to business
combinations, (ii) revaluation profit or loss accounted for following a loss of control, and (iii) changes in earn-outs relating to business combinations and
subsequent to acquisition date.
Recurring operating margin is defined as the Recurring operating income over Net sales ratio.
I 56 I
Financial indicators not defined in IFRS
Non-recurring results from associates include significant items that, because of their exceptional nature, cannot be viewed as inherent to the recurring activity
of those companies and distort the reading of their performance. They include primarily (i) capital gains and losses on disposal and impairment of Investments in
associates, and (ii) when material, non-recurring items as defined by Danone included in the net income from associates.
Recurring net income (or Recurring net income Group Share) corresponds to the Group share in the Total Recurring net income. Total Recurring net income
measures Danones recurring performance and excludes significant items that, because of their exceptional nature, cannot be viewed as inherent to its recurring
performance. Such non-recurring income and expenses mainly include capital gains and losses on disposals and impairments of Investments in associates and
in other non-fully-consolidated and tax income and expenses related to non-recurring income and expenses. Such income and expenses excluded from Net
income are defined as Total Non-recurring net income and expenses.
Recurring income tax rate measures the income tax rate related to Danones recurring performance and corresponds to the Total Recurring net income over tax
income and expenses related to non-recurring income and expenses.
Recurring EPS (or Recurring net income Group Share, per share after dilution) is defined as the Recurring net income over Diluted number of shares ratio.
Free cash-flow represents cash-flows provided or used by operating activities less capital expenditure net of disposals and, in connection with of IFRS 3
(Revised), relating to business combinations, excluding (i) acquisition costs related to business combinations, and (ii) earn-outs related to business combinations
and paid subsequently to acquisition date.
Free cash-flow excluding exceptional items represents free cash-flow before cash-flows related to initiatives deployed within the framework of the plan to
generate savings and adapt Danones organization in Europe.
Net financial debt represents the net debt portion bearing interest. It corresponds to current and non-current financial debt (i) excluding Liabilities related to put
options granted to non-controlling interests and (ii) net of Cash and cash equivalents, Short term investments and Derivatives assets.
I 57 I